ClinicalTrials.Veeva

Menu

Expanding Access to Safe Water in Nigeria

University of Michigan logo

University of Michigan

Status

Enrolling

Conditions

Chlorination

Treatments

Behavioral: Community Demonstrations
Behavioral: Redemption points

Study type

Interventional

Funder types

Other

Identifiers

NCT07246824
HUM00277959

Details and patient eligibility

About

Access to safe water remains a pressing public health challenge in Nigeria, where 67% of the population lacks safely managed drinking water and waterborne diseases cause an estimated 70,000 child deaths annually. Building on evidence that point-of-use chlorination is highly cost-effective in reducing diarrheal disease, this study evaluates a scalable, community-based chlorine distribution model through a cluster-randomized controlled trial (RCT) in Kano State. Thirty communities across four Local Government Areas will be randomly assigned to one of three groups: (i) 20 treatment communities receiving community demonstrations and local chlorine redemption points, (ii) 10 control communities where no intervention will be conducted. After 3 months, 5 control communities will receive an individual-level sensitization and a voucher program and 5 will remain pure control communities. The RCT aims to estimate the causal impact of the community-based intervention on household chlorination rates, water quality (E. coli contamination), and knowledge of safe water practices over six months. By rigorously testing a community-led water treatment model, this study contributes new evidence on sustainable and cost-effective approaches to expand safe water access in low-resource settings. The results will inform national and regional strategies for scaling point-of-use chlorination across sub-Saharan Africa.

Enrollment

700 estimated patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant mothers and women with children under 5 children

Exclusion criteria

  • Men, women with no children under 5 years old

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

700 participants in 2 patient groups

Treatment
Experimental group
Description:
Community Demonstrations and Redemption Points
Treatment:
Behavioral: Redemption points
Behavioral: Community Demonstrations
Control
No Intervention group
Description:
Neither community distributions will be conducted nor redemption points will be set-up during the study period

Trial contacts and locations

1

Loading...

Central trial contact

Elisa Maria Maffioli, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems